Meningococcal Vaccines Market Is Driven By Awareness of the Disease | GlaxoSmithKline, Sanofi Pasteur, Pfizer

Meningococcal vaccines are vaccines that are used to protect against meningococcal disease, which is caused by the bacteria Neisseria meningitidis. Meningococcal disease is a serious, life-threatening infection that can cause meningitis (inflammation of the lining of the brain and spinal cord) and sepsis (blood infection). It is spread through direct contact with respiratory secretions, such as saliva, from an infected person.

Download Sample PDF Of This Report:
https://www.globalinsightservices.com/request-sample/GIS25745/?utm_id=1018

Key Trends
One of the key trends in meningococcal vaccines technology is the development of conjugate vaccines. Conjugate vaccines are composed of a polysaccharide antigen, which is linked to a protein, that are used to increase the immunogenicity of the vaccine. These vaccines are more effective than traditional polysaccharide vaccines, which are composed of just the polysaccharide antigen, as they produce a stronger immune response and provide longer-term protection. The first meningococcal conjugate vaccine, Menactra, was approved in 2005 and it provides protection against serogroups A, C, W-135, and Y.

Another key trend in meningococcal vaccines technology is the development of vaccines that provide protection against additional serogroups. Currently, there are vaccines available to protect against serogroups A, C, W-135, and Y, but there are other serogroups, such as B and X, that are not covered by existing vaccines. Research is being conducted to develop new vaccines that could potentially provide protection against these additional serogroups. In addition, new vaccines are being developed to target specific strains of meningococcal disease, which could potentially provide more effective protection against the disease.

Request Customization:
https://www.globalinsightservices.com/request-customization/GIS25745/?utm_id=1018

Key Drivers
Awareness of the disease is a key driver of the meningococcal vaccines market, as it is important for people to know about the disease and the dangers it poses. This is especially true in developing countries, where access to healthcare and information about the disease is limited. Awareness campaigns, such as those run by the World Health Organization (WHO), have helped to increase knowledge of the disease and the importance of vaccination.

The prevalence of meningococcal disease is also a key driver of the meningococcal vaccines market. The disease is most common in infants and young children, and can be fatal if not treated quickly. As such, there is an increased demand for vaccines to protect against the disease. Additionally, the prevalence of the disease is increasing in certain parts of the world due to a combination of factors, such as poverty, overcrowding, and lack of access to healthcare.

Market Segments
The global Meningococcal Vaccines Market is segmented by type of vaccine, age group, distribution channel, and region. By type of vaccine, the market is divided into conjugate meningococcal vaccines, polysaccharide meningococcal vaccines . Based on age group, it is bifurcated into pediatric meningococcal vaccines, and adult meningococcal vaccines. On the basis of distribution channel, the market is classified into hospitals, clinics, retail pharmacies, and online pharmacies. Region-wise, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.

Key Players
The global Meningococcal Vaccines Market report includes players like GlaxoSmithKline (GSK) - United Kingdom, Sanofi Pasteur - France, Pfizer - United States, Merck & Co., Inc. - United States, Novartis (now part of Novartis Vaccines & Diagnostics) - Switzerland, Serum Institute of India - India, Bio-Manguinhos (Fiocruz) - Brazil, Beijing Institute of Biological Products - China, Chongqing Zhifei Biological Products - China, and Bharat Biotech - India.

Procure Complete Report (PDF with Insights, Charts, Tables, and Figures)
https://www.globalinsightservices.com/checkout/single_user/GIS25745/?utm_id=1018

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.